Lung Carcinoma, Non-Small-Cell
Showing 1 - 25 of >10,000
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Cetuximab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 2, 2023
Double-dose Furmonertinib in Treatment of Slow
Not yet recruiting
- Non Small Cell Lung Cancer
- +3 more
- (no location specified)
Oct 31, 2023
Metabolic Response to Food in Advanced Lung Cancer
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Weight loss (%)
- (no location specified)
Jun 30, 2023
Specific Protein Overexpression in Adult Non-Small Cell Lung
Not yet recruiting
- Non Small Cell Lung Cancer
- (no location specified)
Sep 29, 2023
NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)
Not yet recruiting
- Non-small Cell Lung Cancer
- +2 more
- Nintedanib, gefitinib, erlotinib, afatinib
- (no location specified)
Oct 2, 2023
Stage IB Non-small Cell Lung Cancer
Completed
- Stage IB Non-Small Cell Lung Carcinoma
-
Shanghai, China180 Fenglin Road
Jul 29, 2023
Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)
Not yet recruiting
- Stage II-IIIB(N2) Non-small Cell Lung Cancer
- TQB2450
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Oct 26, 2023
NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Cadonilimab
- +2 more
-
Wuhan, Hubei, ChinaQian Chu
Aug 18, 2023
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy
Not yet recruiting
- Lung Cancer, Non-small Cell
- Small Cell Lung Cancer
- (no location specified)
Nov 16, 2022
NSCLC Trial in Shanghai
Not yet recruiting
- Non-small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jul 20, 2023
NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- Toripalimab
- +2 more
-
Yangzhou, Jiangsu, ChinaPeople's hospital of northern jiangsu
Sep 26, 2023
Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Self-administered survey at hospital
- +2 more
- (no location specified)
Oct 3, 2023
Carcinoma, Non-Small Cell Lung Trial in Zhengzhou (BAI combine with DEB-BACE)
Not yet recruiting
- Carcinoma, Non-Small Cell Lung
- BAI combine with DEB-BACE
-
Zhengzhou, Henan, ChinaGang Wu
Nov 7, 2023
NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)
Not yet recruiting
- Non-small Cell Lung Cancer
- Tirelizumab;Chemotherapy monotherapy
- (no location specified)
Jul 27, 2023
China With Non-Small-Cell Lung Cancer That is Unable to be
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- (no location specified)
May 16, 2023
Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically
Recruiting
- Nonsmall Cell Lung Cancer
- +3 more
- Genomically Guided Radiation Therapy (RT)
-
Tampa, FloridaMoffitt Cancer Center
May 23, 2023
NSCLC Trial in Beijing
Recruiting
- NSCLC
-
Beijing, ChinaYuyan Wang
Oct 10, 2023
NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Sugemalimab and Chemotherapy
-
Changsha, ChinaHunan Cancer Hospital
Jul 7, 2023
NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))
Not yet recruiting
- Non-small Cell Lung Cancer
- Durvalumab
- +2 more
-
Iowa City, IowaUniversity of Iowa
Oct 10, 2023
NSCLC Trial (KB-GDT-01)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- KB-GDT-01
- (no location specified)
Sep 29, 2023
Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma
Active, not recruiting
- Non Small Cell Lung Cancer
- Immune signature in serum associated to the metabolic signature
- Meta-genomic signature of intestinal flora
-
La Tronche, Isère, FranceUniversity Hospital, Grenoble
Jan 6, 2023
Extensive Stage Small Cell Lung Cancer
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer hospital
Aug 6, 2023